If you watched the other presentations, he clearly had far more taxing questions coming through (mostly from you guys probably) than other presenters. They sell the webinars as a vehicle for investors to connect, but clearly just cherry pick the soft questions.
I am invested in a call option with OSX IMO. The delta of that call option recently ticked up nicely if the price didn't. This company has everything in place to become a real innovator in the market. But it needs some cash quickly. I suspect these JV's will reveal a cash injection pretty soon. Like I said, $10 million from Temasek would be nothing to them and indirectly it will sort something - a little you scratch my back business arrangement with a Chinese client or something. Now OSX has signed an MOU with Innoventure that is invested by the venture capital arm of Temasek, I expect something to be announced soon.
As said before Singapore is a "Dingiste" economy where the government via Temasek plays a massive role in the economy. It desperately needs ventures outside of being a tourism and trade hub. Its throwing money at lots of alternatives. Some money coming from the third Chinese JV investor, negotiated behind the scenes by Vertex (Temasek):
"Following the JV’s creation, Osteopore will provide InnoVentures with an exclusive royalty-free license for specific intellectual property (IP) in return for a 30% equity in the JV. InnoVentures has identified a prospective investor, a leading medical device and pharmaceuticals company in China, who has expressed interest in participating in the JV. InnoVentures will contribute efforts towards raising capital, recruiting, and retaining a support organisation to support the JV" (my embolden)
- Forums
- ASX - By Stock
- OSX
- Ann: Investor Webinar Presentation
OSX
osteopore limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: Investor Webinar Presentation, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.830M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.0¢ | $33.27K | 2.901M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 3031165 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 305868 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 1841165 | 0.010 |
12 | 1672765 | 0.009 |
3 | 500000 | 0.008 |
3 | 542857 | 0.007 |
1 | 200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 305868 | 2 |
0.014 | 38500 | 1 |
0.015 | 572510 | 2 |
0.016 | 684274 | 2 |
0.017 | 135555 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online